Preview

Diabetes mellitus

Advanced search

Pharmacoeconomic aspects of the treatment of diabetic foot syndrome

https://doi.org/10.14341/2072-0351-5686

Abstract

Treatment of patients with diabetic foot syndrome (DFS) is a major medico-social problem facing public health services. One of its important aspectsis high cost of the treatment. In connection with this, not only medical but also economic issues pertinent to DFS have recently been widely discussedin different countries. Clinico-economic analysis of the use of new medicinal products, therapeutic modalities, and established medical technologiesis of primary importance for making decisions concerning allocation of available financial resources. The present review of foreign publications focuseson the studies providing additional arguments in favour of modern efficacious methods for the management of DFS. The review is intended to motivateclinicians and health officials to revise current approaches to the treatment of DFS patients in this country.

About the Authors

Marina Fedorovna Kalashnikova
I.M.Sechenov Moscow Medical Academy, Moscow


Nadezhda Viktorovna Maksimova
I.M.Sechenov Moscow Medical Academy, Moscow


Oleg Viktorovich Udovichenko
Local Diabetic Foot Cabinet, South-Western administrative district, Moscow


Yury Ivanovich Suntsov
Endocrinological Research Centre, Moscow


References

1. Дедов И.И., Шестакова М.В. Сахарный диабет. Руководство для врачей. - М.: Универсум Паблишинг, 2003.

2. International Consensus on the Diabetic Foot and Practical Guidelines on the Management and the Prevention of the Diabetic Foot // International Working Group on the Diabetic Foot. - 2007. - www.iwgdf.org.

3. Сунцов Ю.И., Дедов И.И., Шестакова М.В. Скрининг осложнений сахарного диабета как метод оценки качества лечебной помощи больным. По результатам 5-летней деятельности научно-практического проекта. - М.: Мобильный Диабет-Центр, 2008.

4. Frykberg R.G. Epidemiology of the diabetic foot: Ulcerations and amputations // Advances in Wound Care. - 1999. - Apr.

5. Katz I.A., Harlan A., Miranda-Palma B., Prieto-Sanchez L., et al. A randomised trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers // Diabetes Care. - 2005. - 28(3). - P. 555-559.

6. Amputations Linked to Diabetes Pierre Lefebvre, president of the International Diabetes Federation, Date: 01 Sep 2005 http:www.hospitalmanagement. net/features/feature627/.

7. Klonoff D.C., Schwartz D.M. An Economic Analysis of Interventions for Diabetes // Diabetes Care. - 2000. - 23. - P. 390-404.

8. Frykberg R.G., Zgonis T., Armstrong D.G., Driver V.R. et al. National Institute for Clinical Excellence Guideline 10 - Type 2 diabetes: prevention and management of foot problems - 2004 // Journal of Foot and Ankle Surgery September. - 2006. - Vol. 45, Issue 5. - P. 1-66.

9. Franks P.J., Gottrup F. Outcomes and Structures of Care: The European Perspective // Wounds. - 2004. - 16(5). - P. 173-182.

10. Анциферов М.Б., Галстян Г.Р., Токмакова А.Ю., Дедов И.И. Синдром нейропатической стопы // Сахарный диабет. - 2001. - № 2.

11. Watkins P.J. Clinical review: The diabetic foot // BMJ. - 2003. - 326. - P. 977-979.

12. Комелягина Е.Ю., Анциферов М.Б. Факторы риска и профилактика синдрома диабетической стопы // РМЖ. - 2003. - том 11, № 27. - С.

13. Постановление Правительства города Москвы от 8 апреля 2008 г. №259-ПП «О Городской целевой среднесрочной программе развития здравоохранения «Столичное здравоохранение» на 2008- 2010 гг.».

14. Багирова В.Л., Колганова Н.А., Раздобарин К.А. Актуальность фармакоэкономических исследований для оптимизации рынка лекарственных препаратов // www.medi.ru, апрель, 2005; том 6. - С. 157. - С. 500-507.

15. Drummond M.F. Economic Evaluation In Health Care // Oxford University Press. 2001.

16. Apelqvist J., Ragnarson -Tennvall G., Larsson J., Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting // Foot Ankle Int. - 1995. - Jul; 16 (7). - P. 388-394.

17. Apelqvist J., Ragnarson-Tennvall G., Persson U., Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation // J. Intern. Med. - 1994. - may; 235 (5). - P. 463-471.

18. Gottrup F. Organization of wound healing services: The Danish experience and the importance of surgery // Wound Repair Regen. - 2003. - 11. - Р. 452-457.

19. Воробьев П.А., Авксентьева М.В., Юрьев А.С., Сура М.В. Клинико- экономический анализ. - М.: Ньюдиамед, 2004.

20. Joshua A. Ray at all. Review of the Cost of Diabetes Complications // Curr. Med. Res. Opin. - 2005. - 21(10). - P. 1617-1629.

21. Karen Stockl, Ann Vanderplas, Eskinder Tafesse, Eunice Chang Costs of Lower-Extremity Ulcers Among Patients With Diabetes // Diabetes Care. - 2004. - vol. 27 № 9. - P. 2129-2134.

22. Harrington C., Zagari M.J., Corea J., Klitenic J. A cost analysis of diabetic lower-extremity ulcers // Diabetes Care. - 2000. - Sep; 23(9) . - Р. 1333-1338.

23. Franks P.J., Gottrup F. Outcomes and Structures of Care: The European Perspective // Wounds. - 2004. - 16(5). - P. 173-182.

24. Prompers L., Huijberts M., Schaper N., Apelqvist J. et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study // Diabetologia. - 2008. - 51. - Р. 1826-1834.

25. Nash T., Bellew J.W., Cunningham M., McCulloch J. Identifying Cause for Advancement to Amputation in Patients with Diabetes: The Role of Medical Care and Patient Compliance // Wound. - 2005. - 17 (2). - P. 32- 36.

26. Klonoff D.C., Schwartz D.M. An Economic Analysis of Interventions for Diabetes // Diabetes Care. - 2000. - 23. - P. 390-404.

27. Бреговский В.Б. Помощь пациентам с синдромом диабетической стопы в Санкт-Петербурге: проблемы и пути их решения // Сахарный диабет. 2009, № 1.

28. Сунцов Ю.И., Дедов И.И., Болотская Л.Л. Экономический эффект использования современных технологий в лечении сахарного диабета // Сахарный диабет. - 2006. - 2. - C. 60-62.

29. Harrington C., Zagari M.J., Corea J., Klitenic J. A cost Analysis of diabetic lover extremity ulcers // Diabetes Care. - 2000. - vol. 23, № 9. - Р.

30. Green M.F., Aliabadi Z., Green В.T. Diabetic foot: Evaluation and Management // South Med. J. - 2002. - 95(1). - P. 95-101.

31. Frykberg R.G. The team approach in diabetic foot management // Adv. Wound. Care. - 1998. - 11. - P. 71-77.

32. Granick M.S., Ladin D.A. The multidisciplinary in-hospital wound care team: Two models // Adv. Wound. Care. - 1998. - 11. - P. 80-83.

33. Zhang P., Engelgau M.M., Norris S.L., Gregg E.W., Narayan K.M.V. Application of Economic Analysis to Diabetes and Diabetes Care // Annals of Internal Medicine. - 2004. - vol. 140, № 11. - Р. 972-977.

34. Frykberg R.G., Zgonis T., Armstrong D.G. et al. Diabetic foot disordes: A Clinical practice guideline (2006 revision) // The Journal of Foot & Ankle Surgery. 2006; Vol. 45, № 5.

35. Wagner E.N., Sandhu N., Newton K.M. et al. Effect of improved glycemic control on health care costs and utilization // JAMA. - 2001. - 285(2). - P. 182-189.

36. Удовиченко О.В., Галстян Г.Р. Применение иммобилизирующих разгрузочных повязок (методика total contact cast) при лечении синдрома диабетической стопы. Методические рекомендации / Под ред. академика Дедова И.И. - М., 2005.

37. Armstrong D.G., Nguyen H.C., Lavery L.A., Van Schie C.H.M., Boulton A.J.M., Harkless L.B. Off-loading the diabetic foot wound: A randomised clinical trial // Diabetes Care. - 2001. - 24(6) . - Р. 1019-1022.

38. Shearer A., Scuffham P., Gordois A., Oglesby A. Predicted costs and outcomes of reduced vibration detection in the UK // The Diabetic Foot. - 2003. - 6(1). - P. 30-37.

39. Katz I.A., Harlan A., Miranda-Palma B., Prieto-Sanchez L., et al. A randomised trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers // Diabetes Care. - 2005. - 28(3). - P. 555-559.

40. Tennvall R.G., Apelqvist J., Eneroth M. Costs of deep foot infections in patients with diabetes mellitus // Pharmacoeconomics. - 2000. - 18. - P. 225-238.

41. Lipsky B.A., Berendt A.R., Deery H.G. Diagnosis and Treatment of Diabetic Foot Infections. The Infectious Diseases Society of America // Clinical Infectious Diseases. - 2004. - 39. - P. 885-910.

42. Boeri C., Bernard L., Lavigne J.P. et al. Management of diabetic foot infections. Clinical practice guidelines // Mйdecine et maladies infectieuses. - 2007. - 37. - P. 14-25.

43. Brunerovб L., Andĕl M. Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome // Vnitr. Lek. - 2003. - Jun; 49 (6) . - Р. 457-464.

44. Eckman M.H., Greenfield S., Mackey W.C., Wong J.B., Kaplan S., Sullivan L., Dukes K., Pauker S.G. To examine the cost-effectiveness of approaches to the diagnosis and treatment of foot infections and suspected osteomyelitis in patients with type 2 diabetes. Journal of the American Medical Association // JAMA. - 1995. - 273 (9). - P. 712-720.

45. Viennet C., Bride, J., Gabiot A.C., Humbert P. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices // J.Wound. Care. - 2003. - 12:10. - Р. 385-390.

46. Xakellis G.C., Chrischilles E.A. Hydrocolloid versus saline gauze dressing in treating pressure ulcers: A cost-effectiveness analysis // Arch. Phys. Med. Rehab. - 1992. - 73. - Р. 463-466.

47. Jurczak F., Dugrй T., Johnstone A., Offori T., Vujovic Z., Hollander D. Randomised clinical trial of hydrofiber dressing with silver versus povidone- iodine gauze in the management of open surgical and traumatic wounds // International Wound Journal March. - 2007. - Vol. 4. - Issue 1. - Р. 66-76.

48. Meaume S., Teot I., Lasareth I. et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study // J. Wound. Care. - 2004. - 13. - P. 10409-10413.

49. Mino Y. Necessity of appropriate treatment and care for pressure ulcers from the viewpoint of cost effectiveness // Nurse Plus One [Japanese] . - 1994. - 4(13). - P. 11-14.

50. Mino Y. Cost-effectiveness in care and treatment of pressure ulcers in 21st century. In: Seikei-geka kango (Orthopedic Nursing) // Medica Shuppan. - 2001. - P. 82-85.

51. Fanucci D., Seese J. Multi-faceted use of calcium alginates. A painless, cost-effective alternative for wound care management // Ostomy Wound Management. - 1991. - 37. - P. 16-22.

52. Ohura T., Sanada H., Mino Y.. Clinical Activity-Based Cost Effectiveness of Traditional Versus Modern Wound Management in Patients with Pressure Ulcers.//Wounds. 2004;16 (5). - P. 157-163;

53. Payne W.G., Posnett J., Alvarez O., Brown-Etris M., et al. A Prospective, Randomized Clinical Trial to Assess the Cost-effectiveness of a Modern Foam Dressing vs. a Traditional Saline // Ostomy Wound Management. 2009; V 55 (2);

54. Удовиченко О.В., Галстян Г.Р., Ерошкин И.А., Ефимов А.А., Носов О.В., Васильев Ю.Г. Применение новых технологий в лечении синдрома диабетической стопы: клинический случай // Лечащий врач. - 2003. - № 10.

55. Radack K., Wyderski R.J. Conservative management of intermittent claudication //Ann. Intern. Med. - 1990. - 113. - P. 135-146.

56. Apelqvist J., Sellman A., Katzman P. et al. Hyperbaric Oxygen Therapy as adjunctive treatment of chronic diabetic foot ulcers // 8th scientific meeting of the DFSG (25-28 september 2009, Slovenia).

57. Brothers T.E., Rios G.A., Robison J.G., Elliot B.M. Justification of intervention for limb-threatening ischemia: asurgical decision analysis // Cardiovasc. Surg. - 1999. - 7. - P. 62-69.

58. Panayiotopoulos Y.P., Tyrrell M.R., Arnold F.J., Korzon-Burakowska A., Amiel S.A., Taylor P.R. Results and cost analysis of distal [crural/pedal] arterial revascularisation for limb salvage in diabetic and non-diabetic patients // Diabet. Med. - 1997. - Mar; 14(3) . - Р. 214-20.

59. Gupta S.K., Veith F.J., Ascer E., Flores S.A., Gliedman M.L. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis // Eur. J. Vasc. Surg. - 1988. - 2. - Р. 151-154.


Review

For citations:


Kalashnikova M.F., Maksimova N.V., Udovichenko O.V., Suntsov Yu.I. Pharmacoeconomic aspects of the treatment of diabetic foot syndrome. Diabetes mellitus. 2010;13(2):113-119. (In Russ.) https://doi.org/10.14341/2072-0351-5686

Views: 680


ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)